| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |